Nkarta Inc

1
NAS:NKTX (USA)   Ordinary Shares
$ 9.60 +0.1 (+1.05%) 10:08 PM EST
At Loss
P/B:
1.59
Market Cap:
$ 471.09M
Enterprise V:
$ 284.95M
Volume:
274.22K
Avg Vol (2M):
2.68M
Volume:
274.22K
At Loss
Avg Vol (2M):
2.68M

Business Description

Nkarta Inc
NAICS : 541714 SIC : 2834
ISIN : US65487U1088

Share Class Description:

NKTX: Ordinary Shares
Description
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of tumor targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
Name Current Vs Industry Vs History
Cash-To-Debt 3.08
Equity-to-Asset 0.73
Debt-to-Equity 0.3
Debt-to-EBITDA -0.68
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -5.8
3-Year EPS without NRI Growth Rate -1.4
3-Year FCF Growth Rate -1.8
Name Current Vs Industry Vs History
5-Day RSI 31.98
9-Day RSI 43.98
14-Day RSI 50.62
6-1 Month Momentum % 327.57
12-1 Month Momentum % 76.96

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.97
Quick Ratio 10.97
Cash Ratio 10.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.4
Shareholder Yield % -6.18

Profitability Rank

Name Current Vs Industry Vs History
ROE % -35.3
ROA % -26.95
ROIC % -102.22
ROC (Joel Greenblatt) % -121.67
ROCE % -31.6

Financials (Next Earnings Date:2024-03-15 Est.)

NKTX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NKTX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Nkarta Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.5
Beta 0.46
Volatility % 182.79
14-Day RSI 50.62
14-Day ATR ($) 0.793472
20-Day SMA ($) 10.139
12-1 Month Momentum % 76.96
52-Week Range ($) 1.28 - 12.2
Shares Outstanding (Mil) 49.07

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nkarta Inc Filings

Filing Date Document Date Form
No Filing Data

Nkarta Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Nkarta Inc Frequently Asked Questions

What is Nkarta Inc(NKTX)'s stock price today?
The current price of NKTX is $9.60. The 52 week high of NKTX is $12.20 and 52 week low is $1.28.
When is next earnings date of Nkarta Inc(NKTX)?
The next earnings date of Nkarta Inc(NKTX) is 2024-03-15 Est..
Does Nkarta Inc(NKTX) pay dividends? If so, how much?
Nkarta Inc(NKTX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1